ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,509, issued on Dec. 23, was assigned to Merus N.V. (Utrecht, Netherlands).
"CLEC12AxCD3 bispecific antibodies and methods for the treatment of disease" was invented by Alexander Berthold Hendrik Bakker (Utrecht, Netherlands), Cornelis Jacob Johannes George Bol (Utrecht, Netherlands), Pieter Fokko Van Loo (Utrecht, Netherlands), Leonardo Andres Sirulnik (Utrecht, Netherlands) and Ernesto Isaac Wasserman (Utrecht, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to means and methods of treating a subject for a CLEC12A positive cancer. In some embodiments the method comprises treating the subject in need thereof with tw...